ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/08/10 | 3,205 | 3,250 | 3,160 | 3,165 | -15 | -0.5% | 67,100 |
| 2018/08/09 | 3,220 | 3,280 | 3,135 | 3,180 | -75 | -2.3% | 68,300 |
| 2018/08/08 | 3,115 | 3,310 | 3,110 | 3,255 | +125 | +4% | 107,700 |
| 2018/08/07 | 3,030 | 3,180 | 3,030 | 3,130 | +30 | +1% | 129,200 |
| 2018/08/06 | 3,230 | 3,250 | 3,080 | 3,100 | -200 | -6.1% | 222,900 |
| 2018/08/03 | 3,435 | 3,465 | 3,295 | 3,300 | -135 | -3.9% | 105,300 |
| 2018/08/02 | 3,280 | 3,450 | 3,280 | 3,435 | +105 | +3.2% | 87,600 |
| 2018/08/01 | 3,405 | 3,445 | 3,325 | 3,330 | -75 | -2.2% | 87,600 |
| 2018/07/31 | 3,340 | 3,430 | 3,260 | 3,405 | +15 | +0.4% | 153,600 |
| 2018/07/30 | 3,555 | 3,555 | 3,385 | 3,390 | -165 | -4.6% | 179,800 |
| 2018/07/27 | 3,550 | 3,585 | 3,510 | 3,555 | +30 | +0.9% | 66,300 |
| 2018/07/26 | 3,615 | 3,630 | 3,520 | 3,525 | -20 | -0.6% | 96,000 |
| 2018/07/25 | 3,585 | 3,590 | 3,540 | 3,545 | -10 | -0.3% | 57,900 |
| 2018/07/24 | 3,620 | 3,635 | 3,530 | 3,555 | -15 | -0.4% | 104,900 |
| 2018/07/23 | 3,655 | 3,715 | 3,565 | 3,570 | -175 | -4.7% | 166,900 |
| 2018/07/20 | 3,810 | 3,870 | 3,720 | 3,745 | -90 | -2.3% | 96,400 |
| 2018/07/19 | 3,785 | 3,895 | 3,740 | 3,835 | +50 | +1.3% | 120,800 |
| 2018/07/18 | 3,650 | 3,820 | 3,650 | 3,785 | +135 | +3.7% | 113,700 |
| 2018/07/17 | 3,660 | 3,715 | 3,640 | 3,650 | -45 | -1.2% | 75,400 |
| 2018/07/13 | 3,700 | 3,730 | 3,655 | 3,695 | +20 | +0.5% | 75,500 |
| 2018/07/12 | 3,640 | 3,705 | 3,610 | 3,675 | +65 | +1.8% | 66,400 |
| 2018/07/11 | 3,650 | 3,680 | 3,530 | 3,610 | -95 | -2.6% | 139,000 |
| 2018/07/10 | 3,730 | 3,765 | 3,655 | 3,705 | +20 | +0.5% | 119,000 |
| 2018/07/09 | 3,780 | 3,875 | 3,625 | 3,685 | -95 | -2.5% | 238,000 |
| 2018/07/06 | 3,630 | 3,780 | 3,575 | 3,780 | +265 | +7.5% | 301,200 |
| 2018/07/05 | 3,845 | 3,935 | 3,450 | 3,515 | -385 | -9.9% | 479,900 |
| 2018/07/04 | 4,075 | 4,075 | 3,780 | 3,900 | -185 | -4.5% | 351,600 |
| 2018/07/03 | 4,590 | 4,630 | 4,065 | 4,085 | -475 | -10.4% | 297,000 |
| 2018/07/02 | 4,885 | 4,885 | 4,555 | 4,560 | -325 | -6.7% | 121,900 |
| 2018/06/29 | 4,745 | 4,885 | 4,705 | 4,885 | +125 | +2.6% | 67,500 |
| 2018/06/28 | 4,800 | 4,805 | 4,700 | 4,760 | -85 | -1.8% | 86,900 |
| 2018/06/27 | 4,870 | 4,930 | 4,655 | 4,845 | +4,356 | +890.8% | 107,400 |
| 2018/06/26 | 466 | 490 | 464 | 489 | +13 | +2.7% | 836,000 |
| 2018/06/25 | 498 | 501 | 476 | 476 | -25 | -5% | 1,205,000 |
| 2018/06/22 | 507 | 510 | 499 | 501 | -13 | -2.5% | 1,310,000 |
| 2018/06/21 | 512 | 518 | 509 | 514 | +2 | +0.4% | 1,301,000 |
| 2018/06/20 | 504 | 513 | 496 | 512 | +7 | +1.4% | 1,653,000 |
| 2018/06/19 | 502 | 508 | 496 | 505 | +2 | +0.4% | 1,654,000 |
| 2018/06/18 | 508 | 515 | 500 | 503 | +2 | +0.4% | 1,586,000 |
| 2018/06/15 | 510 | 512 | 499 | 501 | -2 | -0.4% | 1,004,000 |
| 2018/06/14 | 517 | 521 | 502 | 503 | -6 | -1.2% | 1,498,000 |
| 2018/06/13 | 504 | 516 | 500 | 509 | +9 | +1.8% | 1,591,000 |
| 2018/06/12 | 479 | 511 | 479 | 500 | +24 | +5% | 3,070,000 |
| 2018/06/11 | 471 | 480 | 470 | 476 | +3 | +0.6% | 1,132,000 |
| 2018/06/08 | 470 | 477 | 466 | 473 | +8 | +1.7% | 1,270,000 |
| 2018/06/07 | 468 | 481 | 464 | 465 | +11 | +2.4% | 2,585,000 |
| 2018/06/06 | 452 | 464 | 450 | 454 | -6 | -1.3% | 1,142,000 |
| 2018/06/05 | 456 | 464 | 450 | 460 | +2 | +0.4% | 1,359,000 |
| 2018/06/04 | 459 | 461 | 453 | 458 | +2 | +0.4% | 921,000 |
| 2018/06/01 | 451 | 461 | 451 | 456 | -1 | -0.2% | 1,060,000 |
1501～
1550
件表示中 / 3553件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 285,000円 | +52.1% | +23.3% | 0.00% | 20.21倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 科研薬 | 386,000円 | +22.8% | +113.0% | 4.92% | 10.29倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 316,000円 | +14.7% | -21.6% | 1.90% | 12.35倍 | 1.00倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 持田薬 | 348,000円 | +3.0% | +27.5% | 2.30% | 22.03倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 232,400円 | +9.6% | +17.5% | 1.98% | 13.13倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
